Bill Ackman Is Still Absolutely Killing It This Year
Reuters/ Eduardo Munoz
Reuters reports that his hedge fund Pershing Square returned 1.4% in September, bringing its year to date return up to 3.15%.
Ackman's most active positions include a big short of Herbalife, which fluctuates between losing him money and going flat; a stake in pharmaceutical company Allergan; and huge stakes Fannie Mae and Freddie Mac - Pershing is the largest shareholder in both stocks.
Fannie and Freddie took a bath this week when a lawsuit to allow shareholders to share in the companies' profits ruled out of hsi favor - both stocks declined up to 40%.
As for Allergan, we'll just have to wait to see how things shake out. Ackman has teamed up with another pharmaceutical company, Valeant, to take over the company. So far Allergan isn't biting.
But the game isn't over yet.
- CEO says he tried to hire an AI researcher from Meta, and was told to 'come back to me when you have 10,000 H100 GPUs'
- We bought a house in Japan for $30,000. We'll have more land than we could afford in the US, and our kids will be more independent.
- Rumors Prince William is having an affair with Rose Hanbury are flooding social media again after Stephen Colbert waded into 'Katespiracy'
- Sensex, Nifty tank in early trade amid weak Asian markets, foreign fund outflows
- Long-Term vs. Short-Term Debt
- Mutual funds stress test: What it means for you
- Businesses should not be built on model, but out of passion: Peyush Bansal
- Delhi world's most polluted capital, Begusarai top polluted metro says IQAir